• Administrator
    Administrator

    £14.25 million funding announced

    To coincide with the publication of the Life Science Industrial Strategy, Health Secretary Jeremy Hunt, announces £14.25 million funding to support 11 NIHR Medtech and In vitro diagnostic Co-operatives (MICs).

    The NIHR MICs will build expertise and capacity in the NHS to develop new medical technologies and provide evidence on commercially-supplied in vitro diagnostic (IVD) tests. Funding will be provided over five years for leading NHS organisations to act as centres of expertise; bringing together patients, clinicians, researchers, commissioners and industry. 

    Dr Louise Wood, Director of Science, Research and Evidence at the Department of Health said:

    “The funding received by the 11 NIHR Medtech and In vitro diagnostic Co-operatives will make a real difference to patient’s lives and provide a focal point for the medtech and in vitro diagnostic industries to develop new technologies and generate the evidence needed by the NHS to support the uptake of new tests”

    The NIHR MICs with launch 1 January 2018 replacing the NIHR Healthcare Technology Co-operatives and NIHR Diagnostic Evidence Co-operatives, incorporating and retaining the remits of both.

    For more information about the NIHR MICs.

    For more information about the Industrial strategy.

    Click to read the story on the NIHR website.

  • Administrator
    Administrator

    NIHR - Primary Care #oneinamillion

    Over one million people in primary care have actively participated in research studies looking at healthier lifestyle, disease diagnosis and prevention, and management of long term illnesses such as diabetes, as reported by the National Institute for Health Research (NIHR).

    Clinical research is the way clinicians in primary care (including GPs, dentists and pharmacists) gather evidence about new treatments, in order to improve patient care in the NHS.

    Simon Denegri is the NIHR National Director for Patients and the Public in Research, he said:

    “This is fantastic news. The nature of the health challenges facing the UK means that GPs, in partnership with patients and carers, have a crucial role to play in developing treatments of patient benefit. That over one million people have volunteered to participate in clinical studies is a mark of how successful this partnership has become. The NIHR hopes that many more people and their families will be encouraged by this to also come forward and help us do more life-saving work. Research cannot happen without them.”

    The NIHR Clinical Research Network provides clinicians with the practical support they need to make research studies happen, so that more research takes place across England, and more patients can take part.

    In April 2006, the NIHR Clinical Research Network created the Primary Care Specialty to bring research opportunities for patients closer to home, where the majority of common illnesses and conditions are treated.

    Of the 7,840 general practices in England, 42 per cent are now active in research. The Network works with key stakeholders to promote the successful delivery of research studies in the NHS and to help plan new studies that will address the needs of patients. Collaboration with the Royal College of General Practitioners (RCGP) has meant that over 1,000 practices are now Research Ready® accredited. See the below Q&A with the RCGP to find out more.

    Professor Paul Wallace has been in the Network since the Primary Care Specialty began. Currently Co Specialty Cluster Lead for Primary Care, he looks back over the last ten years:

    "This is very exciting news, and it is really wonderful that we are reaching such a large proportion of the population. People all over the country now have the opportunity to take part in research in their local community as well as at their hospital. We have come a long way thanks to the Network, which has enabled us to give so many practices the mechanisms to help their patients get involved with research.

    “To see the proportion of research active practices grow over the years has been phenomenal and reaching this milestone is a tribute to Network staff, primary care staff but above all, patients and the public who have given their time freely to make a difference in the NHS.”

    In 2015/16 there were 249 open studies on the NIHR Clinical Research Network Primary Care Portfolio. The Primary Care Specialty also supports or is involved in research relating to the other 29 Network specialties such as Diabetes, Respiratory and Mental Health. This means that last year the Primary Care Specialty supported over one quarter of the recruitment to the NIHR Clinical Research Network Portfolio (total recruitment over 605,000).

    Click here to learn more at the NIHR website.

  • Administrator
    Administrator

    NIHR DEC Leeds wins bid

    NIHR DEC Leeds has been successful in its bid to become one of the Government’s newly-funded MedTech & In Vitro Diagnostic Co-operatives.

    The new organisation, called NIHR Leeds In Vitro Diagnostics Co-operative (NIHR Leeds IVD Co-operative), will launch on 1 January 2018, and will be led by Professor Gordon Cook, who is taking over as Clinical Director from Professor Peter Selby.

    "Leeds hosting this very important infrastructure programme is a fantastic opportunity to bring together several talented researchers in Leeds to interface with industry and academia to impact diagnosis and ultimately benefit patients,” says Professor Cook.” We will build on the excellent work of NIHR DEC (Leeds) moving forward to generating more successful interactions and outcomes"

    NIHR Leeds IVD Co-operative is one of 11 MICs established nationwide to build expertise and capacity in the NHS to develop new medical technologies and provide evidence on commercially-supplied in vitro diagnostic (IVD) tests. In particular, NIHR Leeds IVD Co-operative will continue to focus on catalysing the generation of high quality evidence on commercially-supplied IVDs that is required by the NHS, industry and other organisations.

    Funding will continue for five years, enabling the MICS to act as centres of expertise, bringing together patients, clinicians, researchers, health commissioners and industry.

    Dr Louise Wood, Director of Science, Research and Evidence at the Department of Health, said: “The funding received by the 11 NIHR Medtech and In Vitro Diagnostic Co-operatives will make a real difference to patients’ lives and provide a focal point for the medtech and in vitro diagnostic industries to develop new technologies and generate the evidence needed by the NHS to support the uptake of new tests.”

    Read more at the NIHR website.

  • Administrator
    Administrator

    Response to Life Sciences Report

    In response to a report by Sir John Bell to the UK government, Sir John Chisholm, Executive Chair of Genomics England said:

    “Genomics England welcomes Sir John Bell’s report to government from the life sciences sector – recognising as it does the critical role that genomics will play in the future health, well-being and economic prosperity of this country.

    The UK has been quick to act on the opportunities of genomics, with significant investment in the 100,000 Genomes Project – harnessing the world’s biggest integrated healthcare system to deliver the world’s largest national sequencing project. Today’s report gives us the blueprint to build on our global lead in genomic science to drive NHS transformation, improve health outcomes and realise material economic benefits for UK plc.”

Contact Us

University of Liverpool

Block A: Waterhouse Buildings

1-5 Brownlow Street

Liverpool L69 3GL

Email: cjmcn@liverpool.ac.uk

Follow us